Cooper PE Ratio 2012-2026 | COO
Current and historical p/e ratio for Cooper (COO) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cooper PE ratio as of April 20, 2026 is 16.52.
| Cooper PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-04-21 | 67.30 | 33.48 | |
| 2026-01-31 | 81.38 | $2.01 | 40.49 |
| 2025-10-31 | 69.91 | $1.87 | 37.39 |
| 2025-07-31 | 70.69 | $2.04 | 34.65 |
| 2025-04-30 | 81.67 | $2.07 | 39.45 |
| 2025-01-31 | 96.55 | $2.07 | 46.64 |
| 2024-10-31 | 104.68 | $1.96 | 53.41 |
| 2024-07-31 | 93.33 | $1.79 | 52.14 |
| 2024-04-30 | 89.06 | $1.70 | 52.39 |
| 2024-01-31 | 93.26 | $1.46 | 63.88 |
| 2023-10-31 | 77.94 | $1.48 | 52.66 |
| 2023-07-31 | 97.82 | $1.39 | 70.37 |
| 2023-04-30 | 95.36 | $1.46 | 65.54 |
| 2023-01-31 | 87.23 | $1.89 | 46.09 |
| 2022-10-31 | 68.34 | $1.94 | 35.22 |
| 2022-07-31 | 81.74 | $2.14 | 38.19 |
| 2022-04-30 | 90.24 | $4.74 | 19.05 |
| 2022-01-31 | 99.55 | $4.69 | 21.23 |
| 2021-10-31 | 104.20 | $14.79 | 7.04 |
| 2021-07-31 | 105.41 | $14.67 | 7.19 |
| 2021-04-30 | 102.68 | $11.86 | 8.66 |
| 2021-01-31 | 90.97 | $11.33 | 8.03 |
| 2020-10-31 | 79.72 | $1.20 | 66.30 |
| 2020-07-31 | 70.70 | $1.40 | 50.68 |
| 2020-04-30 | 71.63 | $1.72 | 41.77 |
| 2020-01-31 | 86.67 | $2.27 | 38.18 |
| 2019-10-31 | 72.70 | $2.33 | 31.17 |
| 2019-07-31 | 84.29 | $2.24 | 37.59 |
| 2019-04-30 | 72.42 | $2.15 | 33.69 |
| 2019-01-31 | 69.64 | $1.85 | 37.74 |
| 2018-10-31 | 64.52 | $0.70 | 91.84 |
| 2018-07-31 | 65.07 | $0.64 | 102.47 |
| 2018-04-30 | 57.12 | $0.65 | 87.88 |
| 2018-01-31 | 61.11 | $0.87 | 70.04 |
| 2017-10-31 | 60.00 | $1.88 | 31.91 |
| 2017-07-31 | 60.90 | $1.74 | 34.95 |
| 2017-04-30 | 50.02 | $1.67 | 30.00 |
| 2017-01-31 | 46.10 | $1.52 | 30.38 |
| 2016-10-31 | 43.95 | $1.40 | 31.45 |
| 2016-07-31 | 45.55 | $1.28 | 35.66 |
| 2016-04-30 | 38.21 | $1.06 | 36.13 |
| 2016-01-31 | 32.74 | $0.99 | 33.23 |
| 2015-10-31 | 38.02 | $1.04 | 36.73 |
| 2015-07-31 | 44.17 | $1.00 | 44.06 |
| 2015-04-30 | 44.43 | $1.23 | 36.27 |
| 2015-01-31 | 39.33 | $1.32 | 29.74 |
| 2014-10-31 | 40.89 | $1.38 | 29.68 |
| 2014-07-31 | 40.13 | $1.51 | 26.58 |
| 2014-04-30 | 32.90 | $1.51 | 21.82 |
| 2014-01-31 | 31.00 | $1.48 | 20.91 |
| 2013-10-31 | 32.22 | $1.49 | 21.62 |
| 2013-07-31 | 31.75 | $1.57 | 20.29 |
| 2013-04-30 | 27.52 | $1.46 | 18.88 |
| 2013-01-31 | 25.27 | $1.36 | 18.61 |
| 2012-10-31 | 23.92 | $1.26 | 18.95 |
| 2012-07-31 | 18.76 | $1.19 | 15.73 |
| 2012-04-30 | 21.96 | $1.08 | 20.38 |
| 2012-01-31 | 17.97 | $0.98 | 18.34 |
| 2011-10-31 | 17.26 | $0.91 | 19.02 |
| 2011-07-31 | 19.05 | $0.87 | 21.83 |
| 2011-04-30 | 18.64 | $0.86 | 21.62 |
| 2011-01-31 | 14.27 | $0.71 | 20.25 |
| 2010-10-31 | 12.28 | $0.61 | 20.21 |
| 2010-07-31 | 9.67 | $0.52 | 18.77 |
| 2010-04-30 | 9.67 | $0.42 | 23.02 |
| 2010-01-31 | 8.78 | $0.53 | 16.57 |
| 2009-10-31 | 6.96 | $0.55 | 12.59 |
| 2009-07-31 | 6.82 | $0.55 | 12.51 |
| 2009-04-30 | 7.13 | $0.52 | 13.65 |
| 2009-01-31 | 4.71 | $0.45 | 10.46 |
| 2008-10-31 | 4.08 | $0.36 | 11.50 |
| 2008-07-31 | 8.35 | $0.06 | 133.57 |
| 2008-04-30 | 8.66 | $0.01 | 0.00 |
| 2008-01-31 | 9.75 | $-0.06 | 0.00 |
| 2007-10-31 | 10.39 | $-0.06 | 0.00 |
| 2007-07-31 | 12.40 | $0.15 | 84.07 |
| 2007-04-30 | 12.63 | $0.22 | 58.76 |
| 2007-01-31 | 11.79 | $0.29 | 40.32 |
| 2006-10-31 | 14.24 | $0.36 | 39.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.894B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |